Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle

NCT04060992 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Ovulation; Failure or Lack of

Interventions

DRUG: Elagolix 200 MG Oral Tablet [Orilissa]

Sponsor

University of Southern California